LT - Natalizumabas, skirtas ligų, kurioms reikalingas gydymas steroidais, gydymui
EN - NATALIZUMAB FOR USE IN TREATING DISEASES NEEDING STEROID TREATMENT
Legal status
Patent revoked (after opposition at EPO)
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) |
INT.CL. |
A61K 39/395 |
(2006.01) |
|
|
A61P 1/00 |
(2006.01) |
|
|
A61P 11/06 |
(2006.01) |
|
|
A61P 37/00 |
(2006.01) |
European patent
(11) |
Number of the document |
1734997 |
(13) |
Kind of document |
T |
(96) |
European patent application number |
05768245.2 |
|
Date of filing the European patent application |
2005-03-30 |
(97) |
Date of publication of the European application |
2006-12-27 |
(45) |
Date of publication and mention of the grant of the patent |
2015-09-02
|
(46) |
Date of publication of the claims translation |
2015-12-28
|
PCT application
(86) |
Number |
PCT/US2005/010848 |
|
Date |
2005-03-30 |
PCT application publication
(87) |
Number |
WO 2005/099776 |
|
Date |
2005-10-27 |
Priority applications
(30) |
Number |
Date |
Country code |
|
558120 P |
2004-04-01
|
US |
Inventors
(72) |
LIEBERBURG, Ivan, US
|
Grantee
(73) |
Biogen MA Inc.,
225 Binney Street, Cambridge, MA 02142,
US
|
Attorney or representative
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
Title
(54) |
Natalizumabas, skirtas ligų, kurioms reikalingas gydymas steroidais, gydymui |
|
NATALIZUMAB FOR USE IN TREATING DISEASES NEEDING STEROID TREATMENT |
Last renewal fee
|
Payment date |
Validity (years) |
Amount |
|
2024-02-20 |
20 |
347.00
EUR
|
Legal status
|
Patent revoked (after opposition at EPO)
|
|
|
Invalidation date |
2024-10-07 |